Insiders Cardiff Oncology, Inc.

Equities

CRDF

US14147L1089

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
3.63 ^USD	-2.94%		+7.08%	+145.27%

02/05	Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024
02/05	Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cardiff Oncology Appoints Fairooz Kabbinavar as Chief Medical Officer	02/23/02	CI
Insider Buy: Cardiff Oncology	19/22/19	MT
Cardiff Oncology Chief Medical Officer Katherine Ruffner to Depart	13/22/13	MT
Cardiff Oncology, Inc. Announces Executive Changes	13/22/13	CI
Cardiff Oncology, Inc Announces Executive Appointments	11/22/11	CI
Insider Buy: Cardiff Oncology	13/21/13	MT
Cardiff Oncology Announces Appointment of James E. Levine as Chief Financial Officer	12/21/12	CI
Cardiff Oncology Announces Appointment of Katherine L. Ruffner, M.D., as Chief Medical Officer	12/21/12	CI
Cardiff Oncology, Inc. Announces Board Changes	10/21/10	CI
Insider Trends: Insider Purchase Continues Cardiff Oncology Positive Trend	24/21/24	MT
Cardiff Oncology, Inc. Announces Executive Changes	22/20/22	CI
Cardiff Oncology, Inc. Appoints Mark Erlander as Director	19/20/19	CI
TrovaGene, Inc. will Change its Name to Cardiff Oncology, Inc	07/20/07	CI
Trovagene, Inc. Announces Executive Changes	06/20/06	CI
TrovaGene, Inc. Expands Board with Addition of Three Industry Leaders	22/20/22	CI
Trovagene Inc. Announces Resignation of Athena Countouriotis as a Director	31/20/31	CI
Trovagene, Inc. Announces Resignation of Dr. Stanley Tennant as Director, Effective December 31, 2018	15/18/15	CI
Trovagene Receives USAN Approval for “Onvansertib” as Nonproprietary Name for First-in-Class, 3rd Generation PLK1 Inhibitor Drug Candidate, PCM-075	15/18/15	CI
Trovagene Announces Executive Changes	23/18/23	CI
Trovagene, Inc. Appoints Athena Countouriotis to the Board of Directors	20/17/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cardiff Oncology, Inc.

Equities

CRDF

US14147L1089

Insiders

Filters